Literature DB >> 24353356

Adrenal Diagnostics: An Endocrinologist's Perspective focused on Hyperaldosteronism.

Peter J Fuller1.   

Abstract

The era of sophisticated high resolution imaging with the consequent identification of previously unrecognised adrenal masses (adrenal incidentalomas), has emphasised the need for an appropriate biochemical approach to define adrenal function. The focus of this testing is on catecholamines from the adrenal medulla (testing that has been rendered relatively straightforward by plasma metanephrine measurements) and the physiological corticosteroids, cortisol and aldosterone, synthesised by the adrenal cortex. The diagnosis of hypercortisolism remains a challenge and has been extensively reviewed. In the context of hypertension and an adrenal incidentaloma, the exclusion of hyperaldosteronism has an importance beyond simple blood pressure control. This review focuses on the recommended approaches to both the diagnosis of hyperaldosteronism and the characterisation of its aetiology. Monogenetic causes of mineralocorticoid hypertension are discussed as are recent developments with respect to both the molecular aetiology and the differential diagnosis of aldosterone-producing adenomas.

Entities:  

Year:  2013        PMID: 24353356      PMCID: PMC3866948     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  37 in total

1.  Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

Authors:  Sheerazed Boulkroun; Felix Beuschlein; Gian-Paolo Rossi; José-Felipe Golib-Dzib; Evelyn Fischer; Laurence Amar; Paolo Mulatero; Benoit Samson-Couterie; Stefanie Hahner; Marcus Quinkler; Francesco Fallo; Claudio Letizia; Bruno Allolio; Giulio Ceolotto; Maria Verena Cicala; Katharina Lang; Hervé Lefebvre; Livia Lenzini; Carmela Maniero; Silvia Monticone; Maelle Perrocheau; Catia Pilon; Pierre-François Plouin; Nada Rayes; Teresa M Seccia; Franco Veglio; Tracy Ann Williams; Laura Zinnamosca; Franco Mantero; Arndt Benecke; Xavier Jeunemaitre; Martin Reincke; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

2.  A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.

Authors:  C A Dorrian; B J Toole; S Alvarez-Madrazo; A Kelly; J M C Connell; A M Wallace
Journal:  Ann Clin Biochem       Date:  2010-04-14       Impact factor: 2.057

3.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

4.  Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.

Authors:  Timothy J Burton; Isla S Mackenzie; Kottekkattu Balan; Brendan Koo; Nick Bird; Dmitri V Soloviev; Elena A B Azizan; Franklin Aigbirhio; Mark Gurnell; Morris J Brown
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

Review 5.  Mechanisms of mineralocorticoid action.

Authors:  Peter J Fuller; Morag J Young
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

Review 6.  A review of the medical treatment of primary aldosteronism.

Authors:  P O Lim; W F Young; T M MacDonald
Journal:  J Hypertens       Date:  2001-03       Impact factor: 4.844

7.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

8.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

Review 9.  The past, present and future of renin-angiotensin aldosterone system inhibition.

Authors:  Robert J Mentz; George L Bakris; Bernard Waeber; John J V McMurray; Mihai Gheorghiade; Luis M Ruilope; Aldo P Maggioni; Karl Swedberg; Ileana L Piña; Mona Fiuzat; Christopher M O'Connor; Faiez Zannad; Bertram Pitt
Journal:  Int J Cardiol       Date:  2012-10-31       Impact factor: 4.164

10.  Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

Authors:  T Mune; F M Rogerson; H Nikkilä; A K Agarwal; P C White
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

View more
  1 in total

1.  Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Niki Katsiki; Konstantinos Petidis; Apostolos Kamparoudis; Panagiotis Petras; Vasiliki Georgopoulou; Stefanos Finitsis; Christodoulos Papadopoulos; Vasilios G Athyros; Michael Doumas; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-02       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.